Skip to content

Uncovering the genetic basis of schizophrenia: which genes matter the most?

Uncovering the genetic basis of schizophrenia: which genes matter the most? - Genetic basis of schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31499
Enrollment
260
Registered
2008-06-03
Start date
2008-09-11
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age between 18 and 50;specific for schizophrenia patients: DSM-IV diagnosis of schizophrenia

Exclusion criteria

Exclusion criteria: - Ferrous objects in or around the body (e.g. braces, glasses, pacemaker, metal fragments) - Drug or alcohol abuse over a period of six months prior to the experiment - History of closed- or open-head injury - History of neurological illness or endocrinological dysfunction - Claustrophobia - Major medical history - Chronic use of medication - History of epilepsy - History of epilepsy in first-degree relatives - Incapability of giving an informed consent - Symptoms indicative of schizophrenia (healthy controls only) - Symptoms indicative of schizophrenia in first-degree relatives (healthy controls only) - pregnancy

Design outcomes

Primary

MeasureTime frame
- Differences in brain activity as measured with functional MRI between siblings with various allele-variants per candidate- gene - Differences in brain activity as measured with fMRI between siblings with psychotic or schizotypic symptoms compared to siblings without such symptoms - Differences in genetic profile of: o Siblings with psychotic or schizotypic symptoms o Siblings without psychotic or schizotypic symptoms o A matched population of healthy controls

Secondary

MeasureTime frame
Brain activity as measured with functional MRI, expressed in percent signal change. Control variables: - behavioural measures, expressed in reaction times (ms) and accuracy - heart rate, expressed in beats per minute (bpm), heart rate variability - respiration, expressed in respiration volume per time

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)